Exploring the consequences of greater price transparency on the dynamics of pharmaceutical markets

Eliana Barrenho and Ruth Lopert
Additional contact information
Eliana Barrenho: OECD
Ruth Lopert: OECD

No 146, OECD Health Working Papers from OECD Publishing

Abstract: For some time, governments, stakeholders and civil society have been voicing the need for greater transparency in pharmaceutical pricing. The 2018 OECD report Pharmaceutical Innovation and Access to Medicines suggested that increased price transparency could promote public accountability, while potentially delivering efficiencies to health systems by including economic considerations in coverage, treatment decisions and budget allocation. Despite this, precisely what should be made more transparent, and how greater transparency would affect the functioning of markets, have been poorly characterised. To help frame the policy debate, the OECD undertook an exploration of the potential consequences of greater price transparency on market dynamics. The work included a roundtable and a series of semi-structured interviews, with participation by 19 experts in pharmaceutical pricing, economics of pharmaceutical markets, competition, and law. With an extensive review of the current practice and relevant literature as a preface, this report presents the key findings from those consultations.

JEL-codes: F6 I10 L1 L2 (search for similar items in EconPapers)
Date: 2022-09-08
New Economics Papers: this item is included in nep-com and nep-reg
References: Add references at CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1787/c9250e17-en (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oec:elsaad:146-en

Access Statistics for this paper

More papers in OECD Health Working Papers from OECD Publishing Contact information at EDIRC.
Bibliographic data for series maintained by (health.contact@oecd.org).